Description USFDA EU compliant API unit near Hyderabad , India is available for equity investment, acquisition. Has great expansion potential adequate manpower. Has sufficient space and capacity for expansion. The expected valuation is Rs.20 Crore (INR).
Indian GMP
Drug licenses
PCB permissions
ISO 9001:2008
Spanish Eu GMP
Russian Product registration
Customer Audits and approvals
Product approval in Latin America
Ready Anti cancer APIs, and few more Tinibs evaluation completed
Handled tough chemistry molecules like Lopinavir, Ritonavir Micafungin, Intermediates and few others
Dedicated R&D group for New product developments in an innovative & patentable route & entry for the regulated market
Capable in handling Tough, Chiral, Polymer, Metal, Peptide chemistry, Anti cancer molecules and so on
Developed 30 product process
50 Products strategies are in place
11 product with full DMF documentation, 6 product with technical package documentation, 3 products under document preparation
Research oriented company, Many of its products developed for the first time in India
Tough chemistry handling and launching one of the very first companies in in India